EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma pill could offer hope for severe cases
Disease control Recruiting nowThis study tests an experimental daily pill, KT-621, in adults with moderate to severe eosinophilic asthma that is not well controlled by current inhalers. The goal is to see if the drug improves lung function and asthma control compared to a placebo. About 264 participants will …
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE2 • Sponsor: Kymera Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
New asthma drug aims to cut attacks in patients not helped by standard inhalers
Disease control Recruiting nowThis study tests whether adding benralizumab (an injectable medication) to usual medium-dose inhaler treatment can reduce asthma attacks and improve quality of life in people with eosinophilic asthma that is not well controlled. About 400 participants aged 12 to 75 will receive e…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 06, 2026 16:14 UTC